ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,084Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 59

$839K Total Retail Price of All Prescriptions

Rank: 11 out of 59

433 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 433 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 12,738 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 694 661 1 3
NEXIUM 501 446 2 14
CILOSTAZOL 427 412 3 95
CRESTOR 386 338 4 23
LISINOPRIL 358 338 5 2
AMLODIPINE BESYLATE 357 351 6 4
ATORVASTATIN CALCIUM 326 292 7 15
TRAMADOL HCL 321 278 8 10
OMEPRAZOLE 282 243 9 7
DIOVAN 271 238 10 38
SIMVASTATIN 252 245 11 1
FUROSEMIDE 249 218 12 8
METOPROLOL TARTRATE 244 237 13 9
JANUVIA 236 210 14 45
GLIMEPIRIDE 198 166 15 47
DONEPEZIL HCL 195 195 16 24
TAMSULOSIN HCL 194 184 17 27
TRAMADOL HCL-ACETAMINOPHEN 190 161 18 77
METOPROLOL SUCCINATE 185 181 19 12
AZITHROMYCIN 173 159 20 32
NAMENDA 171 171 21 29
MECLIZINE HCL 166 164 22 72
POTASSIUM CHLORIDE 162 157 23 16
AMLODIPINE BESYLATE-BENAZEPRIL 158 126 24 61
GLYBURIDE-METFORMIN HCL 158 117 R 24 59
MELOXICAM 146 135 26 26
CITALOPRAM HBR 126 94 27 25
CLOPIDOGREL 124 117 28 35
BUMETANIDE 121 120 29 148
ALENDRONATE SODIUM 120 120 30 20
ZOLPIDEM TARTRATE 116 105 31 17
METFORMIN HCL 115 97 32 6
BUSPIRONE HCL 111 105 33 150
TRICOR 108 103 34 79
PLAVIX 106 99 35 54
ATENOLOL 105 86 36 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 92 37 60
HYDROCHLOROTHIAZIDE 96 96 38 11
TRILIPIX 95 76 39 120
CEPHALEXIN 95 83 39 112
HYDROCODONE BIT-IBUPROFEN 93 67 S3 41 185
ENALAPRIL MALEATE 92 78 42 49
IBUPROFEN 88 70 43 62
LIPITOR 87 75 44 83
SERTRALINE HCL 87 67 44 22
MEGESTROL ACETATE 85 83 R 46 127
GABAPENTIN 83 71 47 13
LOSARTAN POTASSIUM 80 62 48 19
ISOSORBIDE MONONITRATE ER 78 78 49 93
CLOBETASOL PROPIONATE 78 64 49 162
CELEBREX 75 74 51 87
SINGULAIR 74 51 52 85
PANTOPRAZOLE SODIUM 71 63 53 33
THEOPHYLLINE ANHYDROUS 71 65 53 203
CIPROFLOXACIN HCL 70 63 55 36
GLYBURIDE 70 57 R 55 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 64 55 18
LOVASTATIN 67 38 58 43
FAMOTIDINE 65 65 59 66
DIGOXIN 65 65 59 64
VYTORIN 64 41 61 212
EXFORGE 64 59 61 212
POLYETHYLENE GLYCOL 3350 64 64 61 75
GLIPIZIDE 64 64 61 52
ZETIA 60 57 65 176
MUPIROCIN 60 54 65 153
DIOVAN HCT 54 49 67 65
PHENYTOIN SODIUM EXTENDED 53 33 68 129
INSULIN SYRINGE 51 50 69 67
PEN NEEDLE 51 41 69 92
ALLOPURINOL 50 50 71 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.